ArticleMethods in molecular biology (Clifton, N.J.)2026
Design and Evaluation of Domain-Rearranged Bispecific Antibody Fragments for Functional Optimization.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bispecific antibody (BsAb) fragments, such as bispecific tandem scFv and bispecific diabody (Db), have a convenient size that allows for rapid tissue penetration and high target retention. Among BsAb fragments, the bispecific Db and bispecific tandem single-chain Fv (taFv) formats are the most widely used. To prevent homodimer formation, a single-chain Db (scDb) was developed by connecting two hetero-scFv fragments with an additional middle linker. The domain order consisting of BsAb fragments can be varied, and several reports have suggested that this order affects both expression levels and function. However, the order of the most functional domains varies depending on the antibody clones used to construct BsAb fragments and their targets, making it difficult to predict. Both bispecific scDb and taFv formats have eight possible domain orders, which also affect expression levels and function. Here, we demonstrated a method for rearranging the domain order and functionally evaluating bispecific scDb and taFv formats.
Indexed as
Identifiers
42108343What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.